ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

CT Scanning Use, Costs, Controls Debated By NCAB

October 7, 1977

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014

Inspector General’s chronology Of Events In Gallo Research

July 1, 1994